FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022696445> ?p ?o ?g. }

• W2022696445 endingPage "426" @default.
• W2022696445 startingPage "420" @default.
• W2022696445 abstract "Recent developments have implicated cannabinoid CB1 receptors as a novel target for a new class of therapeutic agents used to treat drug addiction. CB1 receptors are expressed in the motivational circuitry of the brain and modulate drug seeking. Blockade of the CB1 receptor is particularly effective in reducing cue-induced reinstatement of drug seeking, an animal analogue of cue-induced relapse in human addicts. These relapse-preventing properties are observed with different classes of abused drug (i.e. psychostimulants, opiates, nicotine and alcohol). In addition, recent evidence indicates a more general role of CB1 receptors in reward-related memories, which is consistent with the proposed role of endocannabinoids in memory-related plasticity. Relapse-preventing actions and inhibitory effects on weight gain were confirmed recently in clinical trials with the CB1 antagonist rimonabant. Collectively, these clinical and preclinical studies suggest that antagonists of CB1 receptors offer a novel approach in the treatment of addictive behaviours. Recent developments have implicated cannabinoid CB1 receptors as a novel target for a new class of therapeutic agents used to treat drug addiction. CB1 receptors are expressed in the motivational circuitry of the brain and modulate drug seeking. Blockade of the CB1 receptor is particularly effective in reducing cue-induced reinstatement of drug seeking, an animal analogue of cue-induced relapse in human addicts. These relapse-preventing properties are observed with different classes of abused drug (i.e. psychostimulants, opiates, nicotine and alcohol). In addition, recent evidence indicates a more general role of CB1 receptors in reward-related memories, which is consistent with the proposed role of endocannabinoids in memory-related plasticity. Relapse-preventing actions and inhibitory effects on weight gain were confirmed recently in clinical trials with the CB1 antagonist rimonabant. Collectively, these clinical and preclinical studies suggest that antagonists of CB1 receptors offer a novel approach in the treatment of addictive behaviours." @default.
• W2022696445 created "2016-06-24" @default.
• W2022696445 creator A5028754896 @default.
• W2022696445 creator A5061197527 @default.
• W2022696445 date "2005-08-01" @default.
• W2022696445 modified "2023-09-29" @default.
• W2022696445 title "Cannabinoid CB1 receptors control conditioned drug seeking" @default.
• W2022696445 cites W1253199717 @default.
• W2022696445 cites W1491109154 @default.
• W2022696445 cites W1513230591 @default.
• W2022696445 cites W1533897695 @default.
• W2022696445 cites W1592286181 @default.
• W2022696445 cites W1593759117 @default.
• W2022696445 cites W1699530412 @default.
• W2022696445 cites W1964739293 @default.
• W2022696445 cites W1965679449 @default.
• W2022696445 cites W1968083340 @default.
• W2022696445 cites W1971698096 @default.
• W2022696445 cites W1975868170 @default.
• W2022696445 cites W1978685420 @default.
• W2022696445 cites W1982291289 @default.
• W2022696445 cites W1986003147 @default.
• W2022696445 cites W1988375731 @default.
• W2022696445 cites W2001109168 @default.
• W2022696445 cites W2009740212 @default.
• W2022696445 cites W2012501502 @default.
• W2022696445 cites W2015109725 @default.
• W2022696445 cites W2016264450 @default.
• W2022696445 cites W2020713586 @default.
• W2022696445 cites W2022391976 @default.
• W2022696445 cites W2025437677 @default.
• W2022696445 cites W2025500270 @default.
• W2022696445 cites W2026219855 @default.
• W2022696445 cites W2029181309 @default.
• W2022696445 cites W2032488758 @default.
• W2022696445 cites W2036218676 @default.
• W2022696445 cites W2036708287 @default.
• W2022696445 cites W2037457092 @default.
• W2022696445 cites W2040903782 @default.
• W2022696445 cites W2044456340 @default.
• W2022696445 cites W2048756351 @default.
• W2022696445 cites W2049900264 @default.
• W2022696445 cites W2057235410 @default.
• W2022696445 cites W2058156920 @default.
• W2022696445 cites W2069472087 @default.
• W2022696445 cites W2070212982 @default.
• W2022696445 cites W2071278141 @default.
• W2022696445 cites W2071693918 @default.
• W2022696445 cites W2072696576 @default.
• W2022696445 cites W2077707065 @default.
• W2022696445 cites W2085155996 @default.
• W2022696445 cites W2086781281 @default.
• W2022696445 cites W2096529235 @default.
• W2022696445 cites W2097215311 @default.
• W2022696445 cites W2098288561 @default.
• W2022696445 cites W2102035457 @default.
• W2022696445 cites W2103263170 @default.
• W2022696445 cites W2103903337 @default.
• W2022696445 cites W2106232499 @default.
• W2022696445 cites W2106862702 @default.
• W2022696445 cites W2130587723 @default.
• W2022696445 cites W2132463990 @default.
• W2022696445 cites W2140159910 @default.
• W2022696445 cites W2151323222 @default.
• W2022696445 cites W2154850432 @default.
• W2022696445 cites W2158593571 @default.
• W2022696445 doi "https://doi.org/10.1016/j.tips.2005.06.002" @default.
• W2022696445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15992935" @default.
• W2022696445 hasPublicationYear "2005" @default.
• W2022696445 type Work @default.
• W2022696445 sameAs 2022696445 @default.
• W2022696445 citedByCount "216" @default.
• W2022696445 countsByYear W20226964452012 @default.
• W2022696445 countsByYear W20226964452013 @default.
• W2022696445 countsByYear W20226964452014 @default.
• W2022696445 countsByYear W20226964452015 @default.
• W2022696445 countsByYear W20226964452016 @default.
• W2022696445 countsByYear W20226964452017 @default.
• W2022696445 countsByYear W20226964452018 @default.
• W2022696445 countsByYear W20226964452019 @default.
• W2022696445 countsByYear W20226964452020 @default.
• W2022696445 countsByYear W20226964452021 @default.
• W2022696445 countsByYear W20226964452022 @default.
• W2022696445 countsByYear W20226964452023 @default.
• W2022696445 crossrefType "journal-article" @default.
• W2022696445 hasAuthorship W2022696445A5028754896 @default.
• W2022696445 hasAuthorship W2022696445A5061197527 @default.
• W2022696445 hasConcept C126322002 @default.
• W2022696445 hasConcept C148001335 @default.
• W2022696445 hasConcept C15744967 @default.
• W2022696445 hasConcept C169760540 @default.
• W2022696445 hasConcept C170493617 @default.
• W2022696445 hasConcept C2776433454 @default.
• W2022696445 hasConcept C2776885963 @default.
• W2022696445 hasConcept C2779547902 @default.
• W2022696445 hasConcept C2780035454 @default.
• W2022696445 hasConcept C2780871563 @default.
• W2022696445 hasConcept C46721173 @default.

• next